The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 372 participants.

Also called NCT01978730

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 372 participants (planned count) (from the registry)
Sponsor
Shineway Pharmaceutical Co.,Ltd (from the registry)
Registry
  • NCT NCT01978730
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01978730. Randomized; quadruple masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2014-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule
Condition
Vascular Dementia
Intervention (Drug)
high dose group of SaiLuoTong capsule
Intervention (Drug)
low dose group of SaiLuoTong
Intervention (Drug)
the control group
Lead sponsor
Shineway Pharmaceutical Co.,Ltd (class: industry)

Record details

Record id
cardio:ct-nct01978730
Content hash
c6884c09ae5559c83c5538cc52dbcb09963da9737d5efa7fa8113a2e679fd68a